ArticleJournal of medical cases2023

Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome.

Hirotomo Machiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.